News

According to the company, the clearance enables it to move forward with the world’s first study of a human embryonic stem cell (hESC)-based therapy in man. Geron plans

Under the collaboration, Corgenix will work with Battelle on biodefense related projects and programs. Under the terms of the collaboration agreement, Corgenix will provide biodefense project support to

Omeprazole delayed-release (DR) capsules are indicated for the treatment of peptic ulcers and gastroesophageal reflux disease. Mylan Pharmaceuticals is shipping this product immediately.

Mr Perez is currently the executive vice president and COO at Cubist Pharmaceuticals, and is responsible for commercial operations, business development, technical operations, the Cubicin development team and

The Selexys Pharmaceutical project is to be executed in Cytovance’s multi-product process development and cGMP production facility in Oklahoma City over the next 15 months. The 44,000sqft facility

Most recently, Mr Renfro was one of Fidelity Investments’s most senior executive officers and a member of the Fidelity executive committee, overseeing several of Fidelity’s non-investment business units.

According to the company, the Press-Fit Total Hip system is a new hip implant system that incorporates a dual taper design. The initial regional release will follow with

Scytera foam is said to be the first coal tar product in an aerosol foam vehicle to be launched into the psoriasis market. Studies have demonstrated that coal

Net income and diluted earnings per share for the 2008 full year were $4.41 billion and $3.27, respectively, compared with $4.61 billion and $3.38, respectively, for the 2007